Malignant Tumors
Also known as: Malignant Tumor / Malignant neoplasm (morphologic abnormality) / Malignant (primary) neoplasm, unspecified / Malignant tumor (disorder) / Neoplasm malignant / Malignant neoplasm NOS / Cancer / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00441 | Gemcitabine | 0 | Completed | 1 |
| DB00196 | Fluconazole | 1 | Completed | 1 |
| DB00959 | Methylprednisolone | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Completed | 1 |
| DB09567 | Olive oil | 1 | Recruiting | 1 |
| DB00338 | Omeprazole | 1 | Completed | 1 |
| DB14805 | Piflufolastat F 18 | 1 | Completed | 1 |
| DB04951 | Pirfenidone | 1 | Recruiting | 1 |
| DB00853 | Temozolomide | 1 | Completed | 1 |
| DB01030 | Topotecan | 1 | Completed | 1 |
| DB15043 | Toripalimab | 1 | Recruiting | 2 |
| DB12077 | Urelumab | 1 | Completed | 1 |
| DB00515 | Cisplatin | 1 / 2 | Recruiting | 1 |
| DB01248 | Docetaxel | 1 / 2 | Recruiting | 1 |
| DB15769 | Envafolimab | 1 / 2 | Suspended | 1 |
| DB00441 | Gemcitabine | 1 / 2 | Recruiting | 1 |
| DB00073 | Rituximab | 1 / 2 | Suspended | 1 |
| DB11127 | Selenious acid | 1 / 2 | Unknown Status | 1 |
| DB14922 | Tislelizumab | 1 / 2 | Recruiting | 1 |
| DB15043 | Toripalimab | 1 / 2 | Suspended | 1 |
| DB00877 | Sirolimus | 2 | Recruiting | 1 |
| DB00633 | Dexmedetomidine | 4 | Completed | 1 |
| DB00693 | Fluorescein | Not Available | Completed | 1 |
| DB00544 | Fluorouracil | Not Available | Recruiting | 1 |
| DB00762 | Irinotecan | Not Available | Recruiting | 1 |
| DB00650 | Leucovorin | Not Available | Recruiting | 1 |